SK

Sumit Kumar

Active Director Director DIN 07711843
DIN 07711843 First appointment Nov 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Nov 2019
Shareholding value •••• Premium profile

About Sumit Kumar

Data last updated:

Sumit Kumar is a Director at Vsaar Pharma Private Limited (since 2021), Director at Wagnerhuber Pharmaceuticals Private Limited (since 2019) and Director at Dcm Pharma Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹8.37 Cr; the largest is Vsaar Pharma Private Limited at ₹4.24 Cr (FY 2025). Earlier, Sumit Kumar was a Director at Proton Pharma Private Limited (2019–2025) and Director at D M Pharma Private Limited (2021–2025).

DIN 07711843
Primary Designation Director
Industry Pharma
First Appointment 01 Nov 2019
Oldest Company Age 16 yrs
Largest company Vsaar Pharma Private Limited · ₹4.24 Cr (FY 2025)
Combined revenue ₹8.37 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vsaar Pharma Private Limited U24232CH2012PTC033851
Director21 Apr 20212012₹4.24 Cr (FY 2025)Active
Director01 Nov 20192010₹2.36 Cr (FY 2025)Active
Dcm Pharma Private Limited U51909CH2020PTC042985
Director13 May 20202020₹1.07 Cr (FY 2024)Active
Alvizia Healthcare Private Limited U47721CH2015PTC035565
Whole-Time Director15 Mar 20212015₹68.6 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Proton Pharma Private Limited U24232CH2012PTC033816
Director01 Nov 20192012Active
D M Pharma Private Limited U33119CH2012PTC033815
Director20 Mar 20212012₹79.75 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Wagnerhuber Pharmaceuticals Private Limited
Vsaar Pharma Private Limited
Alvizia Healthcare Private Limited
Dcm Pharma Private Limited
Premium access

Shareholding and investment profile for Sumit Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Kumar

Sumit Kumar currently holds 4 directorships: Vsaar Pharma Private Limited (Director, since 21 Apr 2021, revenue ₹4.24 Cr (FY 2025)); Wagnerhuber Pharmaceuticals Private Limited (Director, since 01 Nov 2019, revenue ₹2.36 Cr (FY 2025)); Dcm Pharma Private Limited (Director, since 13 May 2020, revenue ₹1.07 Cr (FY 2024)); Alvizia Healthcare Private Limited (Whole-Time Director, since 15 Mar 2021, revenue ₹68.6 Lakh (FY 2025)).

Sumit Kumar was first appointed on 01 Nov 2019 as Director at Wagnerhuber Pharmaceuticals Private Limited. The most recent appointment on record is 21 Apr 2021 at Vsaar Pharma Private Limited.

The 4 current companies of Sumit Kumar that report revenue have a combined latest revenue of ₹8.37 Cr: Vsaar Pharma Private Limited ₹4.24 Cr (FY 2025); Wagnerhuber Pharmaceuticals Private Limited ₹2.36 Cr (FY 2025); Dcm Pharma Private Limited ₹1.07 Cr (FY 2024); Alvizia Healthcare Private Limited ₹68.6 Lakh (FY 2025).

Sumit Kumar held 2 earlier board appointments: Proton Pharma Private Limited (Director, 01 Nov 2019 to 18 Jul 2025); D M Pharma Private Limited (Director, 20 Mar 2021 to 18 Jul 2025).

The current boards of Sumit Kumar's companies include Radhe Sham Goyal (Vsaar Pharma Private Limited), Rakesh Kumar Rana (Vsaar Pharma Private Limited), Ashwani Bhalla (Wagnerhuber Pharmaceuticals Private Limited), Virender Kumar (Wagnerhuber Pharmaceuticals Private Limited), Abhinav Aggarwal (Dcm Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available